INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

SOPHSOPHiA GENETICS SA

CIK 0001840706

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells0 / 52
Max Insider Score29
Connections15with evidence

SOPH · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$29K
4,000 sh
Oct 13, 2026Oct 14, 2026
traded Oct 13, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Telecommunications & technologySEC SIC 7374 · Services-Computer Processing & Data Preparation · Nov 4, 2026
  • ← Insider ofevidence
    Hibbs Kathy LDirector · Jun 22, 2026
  • ← Insider ofevidence
    Cox TroyDirector · Jun 22, 2026
  • ← Insider ofevidence
    Ossipow VincentDirector · Jun 22, 2026
13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL
$36K
5,000 sh
Oct 12, 2026
Oct 14, 2026
traded Oct 12, 2026
+2d
SEC FORM 4

Evidence

16
CJ
Camblong JurgiDirector, Executive Chairman
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$62K
8,500 sh
Oct 12, 2026Oct 14, 2026
traded Oct 12, 2026
+2dSEC FORM 4

Evidence

19
CJ
Camblong JurgiDirector, Executive Chairman
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$327K
40.2K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

16
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$50K
6,168 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$60K
7,394 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$60K
7,394 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

16
MR
Muken RossDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$80K
9,838 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

29
PK
Puylaert KevinChief Sales Officer
SOPHSOPHiA GENETICS SA
Open-market sale
SELL$246
31 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

29
PK
Puylaert KevinChief Sales Officer
SOPHSOPHiA GENETICS SA
Open-market sale
SELL$1,491
185 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

13
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$34K
4,240 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

13
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$43K
5,284 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

13
CG
Cardoza GeorgeChief Financial Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$13K
1,592 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

13
CG
Cardoza GeorgeChief Financial Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$6,447
774 sh
Sep 21, 2026Sep 22, 2026
traded Sep 21, 2026
+1dSEC FORM 4

Evidence

13
MR
Muken RossDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,515
422 sh
Sep 21, 2026Sep 22, 2026
traded Sep 21, 2026
+1dSEC FORM 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$32K
4,000 sh
Sep 14, 2026Sep 16, 2026
traded Sep 14, 2026
+2dSEC FORM 4

Evidence

29
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale
SELL$39K
5,000 sh
Sep 14, 2026Sep 16, 2026
traded Sep 14, 2026
+2dSEC FORM 4

Evidence

13
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$47K
6,168 sh
Sep 11, 2026Sep 14, 2026
traded Sep 11, 2026
+3dSEC FORM 4

Evidence

16
CJ
Camblong JurgiDirector, Executive Chairman
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$65K
8,500 sh
Sep 10, 2026Sep 14, 2026
traded Sep 10, 2026
+4dSEC FORM 4

Evidence

23
HL
Hibbs Kathy LDirector
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$51K
6,250 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$89K
10.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

27
HL
Hibbs Kathy LDirector
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$54K
6,250 sh
Aug 25, 2026Aug 26, 2026
traded Aug 25, 2026
+1dSEC FORM 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$43K
5,000 sh
Aug 25, 2026Aug 26, 2026
traded Aug 25, 2026
+1dSEC FORM 4

Evidence

22
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$41K
5,000 sh
Aug 19, 2026Aug 26, 2026
traded Aug 19, 2026
+7dSEC FORM 4

Evidence

13
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$44K
5,000 sh
Aug 24, 2026Aug 26, 2026
traded Aug 24, 2026
+2dSEC FORM 4

Evidence

0
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Option exercise · 10b5-1 plan
M—
10.0K sh
Aug 19, 2026Aug 21, 2026
traded Aug 19, 2026
+2dSEC FORM 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$45K
5,408 sh
Aug 21, 2026Aug 21, 2026
traded Aug 21, 2026
+0dSEC FORM 4

Evidence

16
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$79K
10.0K sh
Aug 19, 2026Aug 21, 2026
traded Aug 19, 2026
+2dSEC FORM 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$39K
4,592 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

0
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Option exercise · 10b5-1 plan
M$32K
10.0K sh
Aug 19, 2026Aug 21, 2026
traded Aug 19, 2026
+2dSEC FORM 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$79K
10.0K sh
Aug 19, 2026Aug 21, 2026
traded Aug 19, 2026
+2dSEC FORM 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$38K
5,000 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$30K
4,000 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC FORM 4

Evidence

16
CJ
Camblong JurgiDirector, Executive Chairman
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$65K
8,500 sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC FORM 4

Evidence

16
CJ
Camblong JurgiDirector, Executive Chairman
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$145K
20.0K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC FORM 4

Evidence

16
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$38K
5,000 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC FORM 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$49K
7,000 sh
Aug 7, 2026Aug 7, 2026
traded Aug 7, 2026
+0dSEC FORM 4

Evidence

0
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Option exercise · 10b5-1 plan
M$23K
7,000 sh
Aug 7, 2026Aug 7, 2026
traded Aug 7, 2026
+0dSEC FORM 4

Evidence

0
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Option exercise · 10b5-1 plan
M$9,840
3,000 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

0
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Option exercise · 10b5-1 plan
M$23K
7,000 sh
Aug 7, 2026Aug 7, 2026
traded Aug 7, 2026
+0dSEC FORM 4

Evidence

4
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Option exercise · 10b5-1 plan
M$9,840
3,000 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$75K
10.0K sh
Aug 7, 2026Aug 7, 2026
traded Aug 7, 2026
+0dSEC FORM 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$21K
3,000 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$38K
7,393 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

16
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$27K
5,285 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

13
CG
Cardoza GeorgeChief Financial Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$8,419
1,592 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

16
MR
Muken RossDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$51K
9,838 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

13
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$21K
4,241 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

16
CJ
Camblong JurgiDirector, Executive Chairman
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$118K
22.5K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$38K
7,393 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

29
PK
Puylaert KevinChief Sales Officer
SOPHSOPHiA GENETICS SA
Open-market sale
SELL$158
31 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

29
PK
Puylaert KevinChief Sales Officer
SOPHSOPHiA GENETICS SA
Open-market sale
SELL$236
47 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

29
PK
Puylaert KevinChief Sales Officer
SOPHSOPHiA GENETICS SA
Open-market sale
SELL$693
138 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

4
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Option exercise · 10b5-1 plan
M—
31.9K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC FORM 4

Evidence

13
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$7,826
1,373 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$186K
31.9K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC FORM 4

Evidence

0
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Option exercise · 10b5-1 plan
M$101K
31.9K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC FORM 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$104K
18.1K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC FORM 4

Evidence

16
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$38K
6,944 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC FORM 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$28K
5,000 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC FORM 4

Evidence

← Insider ofevidence
Cossery Jean-Michel
Director · Jun 22, 2026
  • ← Insider ofevidence
    Hirsch DidierDirector · Jun 22, 2026
  • ← Insider ofevidence
    Verma AbhimanyuChief Technology Officer · Apr 8, 2026
  • ← Insider ofevidence
    Xu ZhenyuChief Scientific Officer · Mar 20, 2026
  • ← Insider ofevidence
    Muken RossPresident · Mar 20, 2026
  • ← Insider ofevidence
    Cardoza GeorgeChief Financial Officer · Mar 20, 2026
  • ← Insider ofevidence
    Camblong JurgiDirector, Chief Executive Officer · Mar 20, 2026
  • ← Insider ofevidence
    Valente ManuelaChief People Officer · Mar 20, 2026
  • ← Insider ofevidence
    Puylaert KevinChief Sales Officer · Mar 20, 2026
  • ← Insider ofevidence
    Van Well DaanChief Legal Officer · Mar 20, 2026
  • ← Insider ofevidence
    Menu PhilippeChief Medical Officer · Mar 20, 2026